The disclosure relates to medical devices, and, more particularly, to an excimer laser system including a means for calibrating laser output to compensate for increased variation in laser optical fibers.
In the medical industry, there are many surgical devices, instruments, and systems comprised of individual components that must work together properly to ensure treatment is performed safely and effectively. It is critical that any given component falls within an acceptable tolerance to ensure that the component physically fits and interacts appropriately with other components and functions as intended.
The actual production of any product (or operation of any system) involves some inherent variation of input and output. Measurement error and statistical uncertainty are also present in all measurements. Accordingly, tolerance is an inherent aspect when designing a device, instrument, or system. The concept of tolerance, sometimes referred to as engineering tolerance, relates to the permissible limit or limits of variation in a physical dimension of the component, a measured value or physical property of the component, spacing between the component and another component, and the like. Accordingly, if a component falls outside of a permissible tolerance (i.e., the component is too small, too large, fails to have acceptable properties, etc.), then the overall device, instrument, or system will fail to perform as designed.
One example of a surgical system composed of multiple components is a medical laser system. The medical laser system generally consists of a laser unit and a separate laser probe having an optical fiber for directing laser radiation from the laser unit to a treatment area. Laser units provide laser light at specific wavelengths and, as a result, may be designed to perform specific procedures. For example, certain procedures may require photocoagulation of a target tissue, which occurs upon delivery of laser radiation at a first wavelength, while other procedures may require photoablation of a target tissue, which occurs upon delivery of laser radiation at a second wavelength. In turn, optical fibers to be used with these laser systems may have specific dimensions, material compositions, and/or functional properties (i.e., operation at specific temperatures and wavelengths) so as to function as intended with the corresponding laser unit.
While current laser units allow for some tolerance (i.e., optical fiber dimensions, properties, or conditions may have some variation without significantly affecting functioning of the laser system), the range of permissible tolerance is exceedingly tight. For example, optical fibers have a very small diameter which is generally measured on the micron scale. The diameter of the optical fiber may impact the transmission of laser radiation through the optical fiber and thus may impact the laser radiation emitted from the delivery tip of the optical fiber. As such, there is very little room for variation in the manufacture of optical fibers. Manufacturing costs are increases as a result of the high degree of precision required to make sure the diameter of an optical fiber falls within the permissible tolerance. Furthermore, if a given optical fiber falls outside of a permissible tolerance (i.e., the diameter is too be or too small), use of the noncompliant optical fiber may result in transmission of laser radiation that is not at the desired wavelength. In turn, use of a noncompliant optical fiber runs the risk of providing an ineffective treatment and, in some instance, can cause additional unintended damage and harm.
The present invention provides a system for calibrating output from a laser source to compensate for increased variation in laser optical fibers. In such a system, the elements generally include a laser source for generating laser energy to be provided to one of a plurality of laser probes coupleable thereto. Each laser probe includes an optical fiber, including a fiber optic core, adapted to direct laser radiation from the laser source, through the fiber, and to a desired the treatment area. The system further includes a laser management system for managing the laser source. The management system includes a control system configured to adjust laser energy output from the laser source to any given laser probe to maintain a consistent level of laser radiation delivered to the target area, despite variation in the fiber optic core of any given laser probe.
More specifically, as part of the initial setup, the control system receives data associated with a laser probe coupled to the laser source. The data may include one or more dimensions of the fiber optic core of the laser probe, including fiber optic core diameter. The data is then analyzed by the controller and, based on the analysis, a determination of an optimum level of laser energy output from the laser source is made. The optimum level of laser energy output from the laser source is based on a correlation of the laser probe data, such as specific dimensions of the fiber optic core, with calibration data. The calibration data may generally include a plurality of sets of values, wherein each set of values may include a laser energy output level from the laser source, a diameter of a fiber optic core of a laser probe to receive the laser energy output level, and the resulting wavelength value of laser radiation emitted from the delivery tip of the laser probe. In a preferred embodiment, the resulting wavelength value of laser radiation to be emitted from the delivery tip remains constant, regardless of the diameter of the fiber optic core. In such an embodiment, the laser management system (i.e., the control system) automatically adjusts the laser energy output level from the laser source (i.e., increases or decreases output level) for any given diameter of a fiber optic core so as to maintain the emission of laser radiation upon a target area at a consistent wavelength, despite variation in the diameter of fiber optic cores from the plurality of laser probes.
Accordingly, the system of the present invention is able to compensate for wide range of variations across a plurality of laser probes by simply adjusting output of the laser source to account for such variations. In turn, the manufacture tolerance for optical fibers improves as less precision is required during the manufacturing process, which reduces overall costs. Furthermore, by fine tuning of the laser output, the laser radiation is maintained at a consistent wavelength, ensuring that the target area is treated as intended and patient safety is maintained.
The invention provides a system for calibrating output from a laser source to compensate for increased variation in laser optical fibers. In such a system, the elements generally include a laser source for generating laser energy to be provided to one of a plurality of laser probes coupleable thereto. Each laser probe includes an optical fiber, including a fiber optic core, adapted to direct laser radiation from the laser source, through the fiber, and to a desired the treatment area. The system further includes a laser management system for managing the laser source. The management system includes a control system configured to adjust laser energy output from the laser source to any given laser probe to maintain a consistent level of laser radiation delivered to the target area, despite variation in the fiber optic core of any given laser probe.
Accordingly, the system of the present invention is able to compensate for wide range of variations across a plurality of laser probes by simply adjusting output of the laser source to account for such variations. In turn, the manufacture tolerance for optical fibers improves as less precision is required during the manufacturing process, which reduces overall costs. Furthermore, by fine tuning of the laser output, the laser radiation is maintained at a consistent wavelength, ensuring that the target area is treated as intended and patient safety is maintained.
The system of the present invention is particularly well suited for intraocular procedures in which laser treatment of target tissues is desired. In particular, the laser source, laser management system, and laser probes of the present invention are preferably used for treating glaucoma and useful in performing a laser trabeculostomy. However, it should be noted that the system consistent with the present disclosure can be used in any laser treatment of various conditions, including other eye conditions (i.e., diabetic eye diseases, such as proliferative diabetic retinopathy or macular oedema, cases of age-related macular degeneration, retinal tears, and retinopathy of prematurity, and laser-assisted in situ keratomileusis (LASIK) to correct refractive errors, such as short-sightedness (myopia) or astigmatism) as well as other conditions in general and other practice areas (non-ocular practice areas).
The laser source 102 includes an excimer laser 104 and a gas cartridge 108 for providing the appropriate gas combination to the laser 104. The excimer laser 104 is a form of ultraviolet laser that generally operates in the UV spectral region and generates nanosecond pulses. The excimer gain medium (i.e., the medium contained within the gas cartridge 106) is generally a gas mixture containing a noble gas (e.g., argon, krypton, or xenon) and a reactive gas (e.g., fluorine or chlorine). Under the appropriate conditions of electrical stimulation and high pressure, a pseudo-molecule called an excimer (or in the case of noble gas halides, exciplex) is created, which can only exist in an energized state and can give rise to laser light in the UV range.
Laser action in an excimer molecule occurs because it has a bound (associative) excited state, but a repulsive (dissociative) ground state. Noble gases such as xenon and krypton are highly inert and do not usually form chemical compounds. However, when in an excited state (induced by electrical discharge or high-energy electron beams), they can form temporarily bound molecules with themselves (excimer) or with halogens (exciplex) such as fluorine and chlorine. The excited compound can release its excess energy by undergoing spontaneous or stimulated emission, resulting in a strongly repulsive ground state molecule which very quickly (on the order of a picosecond) dissociates back into two unbound atoms. This forms a population inversion. The excimer laser 104 of the present system 100 is an XeCl excimer laser and emits a wavelength of 308 nm.
The laser management system 108 manages the laser source 102. In particular, as shown in
As part of the initial setup, the controller 110 receives data associated with a laser probe coupled to the laser source 102. In this instance, data from laser probe 200 is provided to the controller 110. This data may be manually entered (via a user interface provided on the system 100) or may be automatically read from readable device or label on the probe 200 via an associated reader of the system 100. The data may include physical characteristics of the probe 200, including, but not limited to, physical dimensions of the fiber optic core 202, one or more measured values or physical properties of the fiber optic core 202, and physical dimensions and/or measured values or physical properties of other components of the probe 200. In one embodiment, the data includes a diameter of the fiber optic core 202.
The data is then analyzed by the controller 110 and, based on the analysis, a determination of an optimum level of laser energy output from the laser source 102 is made. The analysis is based on a correlation of the laser probe data, such as specific dimensions of the fiber optic core, with calibration data. The calibration data is stored in a database, either a local database (i.e., calibration database 112) forming part of the laser unit system 100, or a remote database hosted via a remote server 300 (i.e., calibration database 302). For example, in some embodiments, the system 100 may communicate and exchange data with a remote server 300 over a network. The network may represent, for example, a private or non-private local area network (LAN), personal area network (PAN), storage area network (SAN), backbone network, global area network (GAN), wide area network (WAN), or collection of any such computer networks such as an intranet, extranet or the Internet (i.e., a global system of interconnected network upon which various applications or service run including, for example, the World Wide Web).
The calibration data may generally include a plurality of sets of values, wherein each set of values may include a laser energy output level from the laser source, a diameter of a fiber optic core of a laser probe to receive the laser energy output level, and the resulting wavelength value of laser radiation emitted from the delivery tip of the laser probe. In a preferred embodiment, the resulting wavelength value of laser radiation to be emitted from the delivery tip remains constant, regardless of the diameter of the fiber optic core. In such an embodiment, the laser management system (i.e., the control system) automatically adjusts the laser energy output level from the laser source (i.e., increases or decreases output level) for any given diameter of a fiber optic core so as to maintain the emission of laser radiation upon a target area at a consistent wavelength, despite variation in the diameter of fiber optic cores from the plurality of laser probes.
The controller 110 may include software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices. “Circuitry”, as used in any embodiment herein, may comprise, for example, singly or in any combination, hardwired circuitry, programmable circuitry such as computer processors comprising one or more individual instruction processing cores, state machine circuitry, and/or firmware that stores instructions executed by programmable circuitry. For example, the controller 104 may include a hardware processor coupled to non-transitory, computer-readable memory containing instructions executable by the processor to cause the controller to carry out various functions of the laser system 100 as described herein, including the calibration process. For example, the controller 110 may include custom, proprietary, known and/or after-developed statistical analysis code (or instruction sets), hardware, and/or firmware that are generally well-defined and operable to receive two or more sets of data and identify, at least to a certain extent, a level of correlation and thereby associate the sets of data with one another based on the level of correlation.
Accordingly, the system of the present invention is able to compensate for wide range of variations across a plurality of laser probes by simply adjusting output of the laser source to account for such variations. In turn, the manufacture tolerance for optical fibers improves as less precision is required during the manufacturing process, which reduces overall costs. Furthermore, by fine tuning of the laser output, the laser radiation is maintained at a consistent wavelength, ensuring that the target area is treated as intended and patient safety is maintained.
As used in any embodiment herein, the term “module” may refer to software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices. “Circuitry”, as used in any embodiment herein, may comprise, for example, singly or in any combination, hardwired circuitry, programmable circuitry such as computer processors comprising one or more individual instruction processing cores, state machine circuitry, and/or firmware that stores instructions executed by programmable circuitry. The modules may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc.
Any of the operations described herein may be implemented in a system that includes one or more storage mediums having stored thereon, individually or in combination, instructions that when executed by one or more processors perform the methods. Here, the processor may include, for example, a server CPU, a mobile device CPU, and/or other programmable circuitry.
Also, it is intended that operations described herein may be distributed across a plurality of physical devices, such as processing structures at more than one different physical location. The storage medium may include any type of tangible medium, for example, any type of disk including hard disks, floppy disks, optical disks, compact disk read-only memories (CD-ROMs), compact disk rewritables (CD-RWs), and magneto-optical disks, semiconductor devices such as read-only memories (ROMs), random access memories (RAMs) such as dynamic and static RAMs, erasable programmable read-only memories (EPROMs), electrically erasable programmable read-only memories (EEPROMs), flash memories, Solid State Disks (SSDs), magnetic or optical cards, or any type of media suitable for storing electronic instructions. Other embodiments may be implemented as software modules executed by a programmable control device. The storage medium may be non-transitory.
As described herein, various embodiments may be implemented using hardware elements, software elements, or any combination thereof. Examples of hardware elements may include processors, microprocessors, circuits, circuit elements (e.g., transistors, resistors, capacitors, inductors, and so forth), integrated circuits, application specific integrated circuits (ASIC), programmable logic devices (PLD), digital signal processors (DSP), field programmable gate array (FPGA), logic gates, registers, semiconductor device, chips, microchips, chip sets, and so forth.
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
The term “non-transitory” is to be understood to remove only propagating transitory signals per se from the claim scope and does not relinquish rights to all standard computer-readable media that are not only propagating transitory signals per se. Stated another way, the meaning of the term “non-transitory computer-readable medium” and “non-transitory computer-readable storage medium” should be construed to exclude only those types of transitory computer-readable media which were found in In Re Nuijten to fall outside the scope of patentable subject matter under 35 U.S.C. § 101.
The terms and expressions which have been employed herein are used as terms of description and not of limitation, and there is no intention, in the use of such terms and expressions, of excluding any equivalents of the features shown and described (or portions thereof), and it is recognized that various modifications are possible within the scope of the claims. Accordingly, the claims are intended to cover all such equivalents.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application is a continuation patent application of U.S. application Ser. No. 16/389,356, filed Apr. 19, 2019, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4607622 | Fritch et al. | Aug 1986 | A |
4846172 | Berlin | Jul 1989 | A |
4862888 | Yessik | Sep 1989 | A |
5281241 | Patel | Jan 1994 | A |
5323766 | Uram | Jun 1994 | A |
5738677 | Colvard et al. | Apr 1998 | A |
5755716 | Garito et al. | May 1998 | A |
6197056 | Schachar | Mar 2001 | B1 |
6283974 | Alexander | Sep 2001 | B1 |
6743221 | Hobart et al. | Jun 2004 | B1 |
7443296 | Mezhinsky | Oct 2008 | B2 |
7568619 | Todd | Aug 2009 | B2 |
9489785 | Klammer | Nov 2016 | B2 |
11076933 | Junger et al. | Aug 2021 | B2 |
11076992 | Junger et al. | Aug 2021 | B2 |
11103382 | Junger et al. | Aug 2021 | B2 |
11234866 | Junger et al. | Feb 2022 | B2 |
11389239 | Junger et al. | Jul 2022 | B2 |
20020013572 | Berlin | Jan 2002 | A1 |
20020183726 | Elbrecht et al. | Dec 2002 | A1 |
20040082939 | Berlin | Apr 2004 | A1 |
20040147985 | MacFarland et al. | Jul 2004 | A1 |
20050192480 | Toriya et al. | Sep 2005 | A1 |
20050283148 | Janssen | Dec 2005 | A1 |
20060111699 | Neuberger | May 2006 | A1 |
20060244652 | Tethrake et al. | Nov 2006 | A1 |
20070122096 | Temelkuran et al. | May 2007 | A1 |
20070147752 | Weisberg et al. | Jun 2007 | A1 |
20070219601 | Neuberger | Sep 2007 | A1 |
20070265602 | Mordaunt et al. | Nov 2007 | A1 |
20080054073 | Charles | Mar 2008 | A1 |
20080082078 | Berlin | Apr 2008 | A1 |
20080097415 | Zimare et al. | Apr 2008 | A1 |
20080108981 | Telfair et al. | May 2008 | A1 |
20080108983 | Nadolski | May 2008 | A1 |
20080161781 | McArdle et al. | Jul 2008 | A1 |
20090118715 | Mansour | May 2009 | A1 |
20090157064 | Hodel | Jun 2009 | A1 |
20100019125 | Stefani et al. | Jan 2010 | A1 |
20100068141 | Kaushal et al. | Mar 2010 | A1 |
20100324543 | Kurtz et al. | Dec 2010 | A1 |
20110295243 | Peyman | Dec 2011 | A1 |
20120275481 | Riggs | Nov 2012 | A1 |
20130041357 | Neuberger | Feb 2013 | A1 |
20130085484 | Van Valen et al. | Apr 2013 | A1 |
20140058367 | Dantus | Feb 2014 | A1 |
20140188096 | Chia et al. | Jul 2014 | A1 |
20140316388 | Hipsley | Oct 2014 | A1 |
20150051607 | Hajishah et al. | Feb 2015 | A1 |
20150148615 | Brennan et al. | May 2015 | A1 |
20150217133 | Angeley et al. | Aug 2015 | A1 |
20150297408 | Dolzan et al. | Oct 2015 | A1 |
20150305811 | Neuberger | Oct 2015 | A1 |
20150374549 | Scott | Dec 2015 | A1 |
20170100041 | Kasamatsu et al. | Apr 2017 | A1 |
20170202708 | Berlin | Jul 2017 | A1 |
20170304001 | Searle et al. | Oct 2017 | A1 |
20180000337 | Chen et al. | Jan 2018 | A1 |
20180042772 | Mansour | Feb 2018 | A1 |
20180263647 | Aljuri et al. | Sep 2018 | A1 |
20180303667 | Peyman | Oct 2018 | A1 |
20180353328 | Bacher et al. | Dec 2018 | A1 |
20180360310 | Berlin | Dec 2018 | A1 |
20190105200 | Hipsley | Apr 2019 | A1 |
20190117459 | Berlin | Apr 2019 | A1 |
20190262071 | Thorn et al. | Aug 2019 | A1 |
20200078217 | Raksi | Mar 2020 | A1 |
20200330157 | Junger et al. | Oct 2020 | A1 |
20200330181 | Junger et al. | Oct 2020 | A1 |
20200330266 | Junger et al. | Oct 2020 | A1 |
20200330274 | Junger et al. | Oct 2020 | A1 |
20200330275 | Junger et al. | Oct 2020 | A1 |
20200330279 | Junger et al. | Oct 2020 | A1 |
20200330280 | Junger et al. | Oct 2020 | A1 |
20200330281 | Junger et al. | Oct 2020 | A1 |
20200390600 | Perera et al. | Dec 2020 | A1 |
20210259880 | Newton et al. | Aug 2021 | A1 |
20210298945 | Juhasz et al. | Sep 2021 | A1 |
20220022997 | Junger et al. | Jan 2022 | A1 |
20220023098 | Junger et al. | Jan 2022 | A1 |
20220031513 | Junger et al. | Feb 2022 | A1 |
20220151828 | Junger et al. | May 2022 | A1 |
20220183887 | Junger et al. | Jun 2022 | A1 |
Number | Date | Country |
---|---|---|
19920615 | Dec 2000 | DE |
10023176 | Nov 2001 | DE |
1835862 | Jun 2011 | EP |
2020215062 | Oct 2020 | WO |
2020215064 | Oct 2020 | WO |
2020215067 | Oct 2020 | WO |
2020215068 | Oct 2020 | WO |
2020215069 | Oct 2020 | WO |
2020215071 | Oct 2020 | WO |
20200215073 | Oct 2020 | WO |
WO 2020215062 | Oct 2020 | WO |
WO 2020215064 | Oct 2020 | WO |
WO 2020215066 | Oct 2020 | WO |
WO 2020215067 | Oct 2020 | WO |
WO 2020215068 | Oct 2020 | WO |
WO 2020215069 | Oct 2020 | WO |
WO 2020215071 | Oct 2020 | WO |
WO 20200215073 | Oct 2020 | WO |
Entry |
---|
Crandall, Alan, “Combining Cataract and Glaucoma Surgery”, Review of Ophthalmology, 1-4, Jun. 13, 2008. |
Grover, Davinder S. “When You Have Cataracts and Glaucoma”, Glaucoma Research Foundation, Oct. 29, 2017. |
Taliaferro, Kevin et al. “Excimer Laser Trabeculostomy Normalizing IOP and Restoring Physiologic Outflow in Glaucoma.” Glaucoma Today, 2009, pp. 45-47 (Year: 2009). |
Toteberg-Harms, et al., “Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP.” BMC ophthalmology, vol. 13, No. 1, p. 24 (2013). |
Tsai, James C. “High Eye Pressure and Glaucoma”, Glaucoma Research Foundation, Oct. 29, 2017. |
International Search Report in International Application No. PCT/US2020/028962 dated Jun. 2, 2020. |
Leung et al., “Anterior Chamber Angle Measurement with Anterior Segment Optical Coherence Tomography: A Comparison between Slit Lamp OCT and Visante OCT” IOVS, pp. 3469-3474, Aug. 2008. |
U.S. Appl. No. 16/389,404 US20200330275A1, filed Apr. 19, 2019 Oct. 22, 2020, Combination Treatment Using Phaco and ELT. |
U.S. Appl. No. 16/389,437 US20200330281A1, filed Apr. 19, 2019 Oct. 22, 2020, Excimer Laser Fiber Illumination. |
U.S. Appl. No. 16/389,346 US20200330181A1, filed Apr. 19, 2019 Oct. 22, 2020, Authentication Systems and Methods for an Excimer Laser System. |
U.S. Appl. No. 17/363,656, filed Jun. 30, 2021, Authentication Systems and Methods for an Excimer Laser System. |
U.S. Appl. No. 16/389,359 US20200330279A1, filed Apr. 19, 2019 Oct. 22, 2020, Calibration System for Improving Manufacture Tolerance in Excimer Laser Optical Fibers. |
U.S. Appl. No. 16/389,446 US20200330266A1, filed Apr. 19, 2019 Oct. 22, 2020, Combination Treatment Using ELT. |
U.S. Appl. No. 16/389,460 US20200330274A1, filed Apr. 19, 2020 Oct. 22, 2020, Methods of Transverse Placement in ELT. |
U.S. Appl. No. 17/363,726, filed Jun. 30, 2021, Methods of Transverse Placement in ELT. |
U.S. Appl. No. 16/389,425 US20200330280A1, filed Apr. 19, 2019 Oct. 22, 2020, Personalization of Excimer Laser Fibers. |
U.S. Appl. No. 16/389,386 US20200330157A1, filed Apr. 19, 2019 Oct. 22, 2020, Enhances Fiber Probes for ELT. |
U.S. Appl. No. 17/842,933, filed Jun. 17, 2022, Combination Treatment Using Phaco and ELT. |
U.S. Appl. No. 17/579,803, filed Jan. 20, 2022, Excimer Laser Fiber Illumination. |
U.S. Appl. No. 16/389,346 US20200330181A1 U.S. Pat. No. 11,076,933, filed Apr. 19, 2019 Oct. 22, 2020 Aug. 3, 2021, Authentication Systems and Methods for an Excimer Laser System. |
U.S. Appl. No. 17/363,656 US20220022997A1, filed Jun. 30, 2021 Jan. 27, 2022, Authentication Systems and Methods for an Excimer Laser System. |
U.S. Appl. No. 16/389,359 US20200330279A1 U.S. Pat. No. 11,103,382, filed Apr. 19, 2019 Oct. 22, 2020 Aug. 31, 2021, Systems and Methods for Performing an Intraocular Procedure for Treating an Eye Condition. |
U.S. Appl. No. 17/592,027 US20220151828A1, filed Feb. 3, 2022 May 19, 2022, Combination Treatment Using ELT. |
U.S. Appl. No. 16/389,460 US20200330274A1 U.S. Pat. No. 11,076,992, filed Apr. 19, 2019 Oct. 22, 2020 Aug. 3, 2021, Methods of Transverse Placement in ELT. |
U.S. Appl. No. 17/363,726 US20220023098A1, filed Jun. 30, 2021 Jan. 27, 2022, Methods of Transverse Placement in ELT. |
U.S. Appl. No. 16/389,425 US20200330280A1 U.S. Pat. No. 11,234,866, filed Apr. 19, 2019 Oct. 22, 2020 Feb. 1, 2022, Personalization of Excimer Laser Fibers. |
U.S. Appl. No. 17/644,930 US20220183887, filed Dec. 17, 2021 Jun. 16, 2022, Personalization of Excimer Laser Fibers. |
U.S. Appl. No. 16/389,386 US20200330157A1 U.S. Pat. No. 11,389,239, filed Apr. 19, 2019 Oct. 22, 2020 Jul. 19, 2022, Enhanced Fiber Probes for ELT. |
U.S. Appl. No. 17/842,971, filed Jun. 17, 2022, Enhanced Fiber Probes for ELT. |
ExTra Operating Instructions, Manufacturer: MLase AG, published prior to Jan. 1, 2018. Third Party Submission. |
Investigation Testing Authorization Application, YUI Laser AG Published Jan. 1, 2016. Third Party Submission. |
Leung et al., “Anterior Chamber Angle Measurement with Anterior Segment Optical Coherence Tomography: A Comparison between Slit Lamp OCT and Visante OCT”, Investigative Ophthalmology & Visual Science, vol. 49, No. 8, pp. 3469-3474, Aug. 2008. |
Berlin, et al., “Excimer Laser Trabeculostomy: An Effective Microinvasive Glaucoma Surgery Procedure for Open-Angle Glaucoma”, published Dec. 19, 2013 Third Party Submission. |
International Search Report in International Application No. PCT/US2020/028967 dated Aug. 23, 2020. |
MLase AG, ExTra Operating Instructions, 37 pages, published prior to Jan. 1, 2018. |
Number | Date | Country | |
---|---|---|---|
20220031513 A1 | Feb 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16389359 | Apr 2019 | US |
Child | 17400191 | US |